Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL EDARAVONE INDUSTRY
2.1 Summary about Edaravone Industry
2.2 Edaravone Market Trends
2.2.1 Edaravone Production & Consumption Trends
2.2.2 Edaravone Demand Structure Trends
2.3 Edaravone Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oral
4.2.2 Injection
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Clinic
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oral
5.2.2 Injection
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Clinic
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oral
6.2.2 Injection
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oral
7.2.2 Injection
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Clinic
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oral
8.2.2 Injection
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oral
9.2.2 Injection
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Clinic
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Mitsubishi Tanabe Pharma
10.1.2 Simcere
10.1.3 Taj Pharmaceuticals Ltd.
10.1.4 Sun Pharmaceutical Industries Ltd.
10.1.5 Unichem Laboratories Ltd
10.1.6 UCB India Ltd
10.1.7 Piramal Healthcare
10.2 Edaravone Sales Date of Major Players (2017-2020e)
10.2.1 Mitsubishi Tanabe Pharma
10.2.2 Simcere
10.2.3 Taj Pharmaceuticals Ltd.
10.2.4 Sun Pharmaceutical Industries Ltd.
10.2.5 Unichem Laboratories Ltd
10.2.6 UCB India Ltd
10.2.7 Piramal Healthcare
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Edaravone Product Type Overview
Table Edaravone Product Type Market Share List
Table Edaravone Product Type of Major Players
Table Brief Introduction of Mitsubishi Tanabe Pharma
Table Brief Introduction of Simcere
Table Brief Introduction of Taj Pharmaceuticals Ltd.
Table Brief Introduction of Sun Pharmaceutical Industries Ltd.
Table Brief Introduction of Unichem Laboratories Ltd
Table Brief Introduction of UCB India Ltd
Table Brief Introduction of Piramal Healthcare
Table Products & Services of Mitsubishi Tanabe Pharma
Table Products & Services of Simcere
Table Products & Services of Taj Pharmaceuticals Ltd.
Table Products & Services of Sun Pharmaceutical Industries Ltd.
Table Products & Services of Unichem Laboratories Ltd
Table Products & Services of UCB India Ltd
Table Products & Services of Piramal Healthcare
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Edaravone Market Forecast (Million USD) by Region 2021f-2026f
Table Global Edaravone Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Edaravone Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Edaravone Market Forecast (Million USD) Share by Demand 2021f-2026f